ALZAMEND NEURO INC (ALZN)

US02262M4078 - Common Stock

0.71  -0.01 (-1.32%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-10-31)
2023
(2023-4-30)
2022
(2022-4-30)
2021
(2021-4-30)
2020
(2020-4-30)
Revenue
0.000.000.000.000.00
Operating Expenses
15.16M14.87M12.32M4.95M4.42M
Research and Development
8.91M7.45M5.20M1.31M1.07M
Selling, General, and Administrative Expenses
6.25M7.42M7.12M3.64M3.35M
Operating Income
-15.16M-14.87M-12.32M-4.95M-4.42M
Interest Income/Expense
-4.31K-10.00K-50.00K-160.00K10.00K
Non Recurring Items
N/A0.000.0060.00KN/A
Income Before Taxes
-15.18M-14.88M-12.36M-5.05M-4.41M
Net Income
-15.18M-14.88M-12.36M-5.05M-4.41M
EBITDA
N/A-14.85MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-2.32-2.29-2.08-0.89-0.78
Non GAAP EPS
-2.39-2.25N/AN/AN/A
 
Statistics

All data in USD

Charts